Małgorzata strengthens the company’s toxicology and risk assessment expertise with special focus on endocrine disruptors, alternative methods application in risk assessment and mode of action analysis. She has over ten year’s experience of cross sector and international work covering governmental agency, academia and industry. She is an expert in the field of endocrine disruption and an author of scientific papers and policy documents in this area.
Małgorzata has skills in investigative/mechanistic toxicology. She has been responsible for the scientific and technical leadership, design, conduct and interpretation of a wide range of studies. A significant part of her previous roles was working with Industry Associations (Cosmetic Europe, BIAC), key opinion formers (OECD) and regulators to advocate alternative assessment approaches.
In her previous role at a multinational consumer goods company Małgorzata provided bespoke risk assessment solutions, developed and applied novel, mechanistic/pathway-based approaches that led and evolved the company’s risk assessment based decision making capability. Prior to that, Małgorzata worked at the European Commission's Joint Research Centre (JRC) in Ispra, Italy as a Scientific Project Officer, specialising in scientific policy support for mode of action based assessment of endocrine disrupting chemicals, with a focus on the development of Adverse Outcome Pathway. Malgorzata has supported the process of establishing the criteria for endocrine disruptors and the impact assessment process leading to guidance on endocrine disruptors.
Małgorzata’s international education includes an MSc in Biotechnology (Poland, Warsaw), a PhD in Molecular biology (France, Paris) and an MSc in Toxicology (Austria, Vienna). Małgorzata is also a registered European Toxicologist (ERT).